Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer.
Pirhonen J, Szkalisity Á, Hagström J, Kim Y, Migh E, Kovács M, Hölttä M, Peränen J, Seppänen H, Haglund C, Gil J, Rezeli M, Malm J, Horvath P, Markó-Varga G, Puolakkainen P, Ikonen E.
Pirhonen J, et al.
Cancer Res. 2022 Nov 2;82(21):3932-3949. doi: 10.1158/0008-5472.CAN-22-0396.
Cancer Res. 2022.
PMID: 36054547